AG-9, an Elastin-Derived Peptide, Increases In Vitro Oral Tongue Carcinoma Cell Invasion, through an Increase in MMP-2 Secretion and MT1-MMP Expression, in a RPSA-Dependent Manner

被引:9
作者
Bretaudeau, Clara [1 ,2 ,3 ]
Baud, Stephanie [1 ,2 ,4 ]
Dupont-Deshorgue, Aurelie [1 ,2 ]
Cousin, Remi [1 ,2 ]
Brassart, Bertrand [1 ,2 ]
Brassart-Pasco, Sylvie [1 ,2 ]
机构
[1] Univ Reims Champagne Ardenne URCA, F-51100 Reims, France
[2] CNRS, UMR 7369, Matrice Extracellulaire & Dynam Cellulaire MEDyC, F-51100 Reims, France
[3] CHU Reims, Serv Odontol, F-51100 Reims, France
[4] URCA, Plateau Modelisat Mol Multiechelle, F-51100 Reims, France
关键词
elastin; ribosomal protein SA; tongue carcinoma; MMP-2; EGCG;
D O I
10.3390/biom11010039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oral tongue squamous cell carcinoma is one of the most prevalent head and neck cancers. During tumor progression, elastin fragments are released in the tumor microenvironment. Among them, we previously identified a nonapeptide, AG-9, that stimulates melanoma progression in vivo in a mouse melanoma model. In the present paper, we studied AG-9 effect on tongue squamous cell carcinoma invasive properties. We demonstrated that AG-9 stimulates cell invasion in vitro in a modified Boyen chamber model. It increases MMP-2 secretion, analyzed by zymography and MT1-MMP expression, studied by Western blot. The stimulatory effect was mediated through Ribosomal Protein SA (RPSA) receptor binding as demonstrated by SiRNA experiments. The green tea-derived polyphenol, (-)-epigallocatechin-3-gallate (EGCG), was previously shown to bind RPSA. Molecular docking experiments were performed to compare the preferred areas of interaction of AG-9 and EGCG with RPSA and suggested overlapping areas. This was confirmed by competition assays. EGCG abolished AG-9-induced invasion, MMP-2 secretion, and MT1-MMP expression.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 47 条
[41]   A receptor for green tea polyphenol EGCG [J].
Tachibana, H ;
Koga, K ;
Fujimura, Y ;
Yamada, K .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (04) :380-381
[42]   Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012 [J].
Tota, Joseph E. ;
Anderson, William F. ;
Coffey, Charles ;
Califano, Joseph ;
Cozen, Wendy ;
Ferris, Robert L. ;
St John, Maie ;
Cohen, Ezra E. W. ;
Chaturvedi, Anil K. .
ORAL ONCOLOGY, 2017, 67 :146-152
[43]   Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA [J].
Toupance, Simon ;
Brassart, Bertrand ;
Rabenoelina, Fanja ;
Ghoneim, Christelle ;
Vallar, Laurent ;
Polette, Myriam ;
Debelle, Laurent ;
Birembaut, Philippe .
CLINICAL & EXPERIMENTAL METASTASIS, 2012, 29 (05) :511-522
[44]   Patented therapeutic approaches targeting LRP/LR for cancer treatment [J].
Vania, Leila ;
Morris, Gavin ;
Otgaar, Tyrone C. ;
Bignoux, Monique J. ;
Bernert, Martin ;
Burns, Jessica ;
Gabathuse, Anne ;
Singh, Elvira ;
Ferreira, Eloise ;
Weiss, Stefan F. T. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (12) :987-1009
[45]   Vascular Extracellular Matrix and Arterial Mechanics [J].
Wagenseil, Jessica E. ;
Mecham, Robert P. .
PHYSIOLOGICAL REVIEWS, 2009, 89 (03) :957-989
[46]  
Weisburg JH, 2004, BASIC CLIN PHARMACOL, V95, P191, DOI 10.1111/j.1742-7843.2004.pto_950407.x
[47]   Survival outcomes after treatment of cancer of the oral cavity (1985-2015) [J].
Zanoni, Daniella Karassawa ;
Montero, Pablo H. ;
Migliacci, Jocelyn C. ;
Shah, Jatin P. ;
Wong, Richard J. ;
Ganly, Ian ;
Patel, Snehal G. .
ORAL ONCOLOGY, 2019, 90 :115-121